Topics View All
Geography View All
Research Activities View All
Trending:
Past Event
Partial Transcript
152 KB
Implementing Comparative Effectiveness Research: Priorities, Methods, and Impact Discussion Papers
1.6 MB
Share
Download Media
Peter Orszag, Director, OMB: Health care reform is complicated and should address two primary needs: to provide coverage for more people and to do so in a more efficient and cost effective manner.
Sen. Max Baucus (D-Mont.): There are national benefits of "comparative effectiveness research" as a means of reforming the nation's ailing health care system.
Robert Rubin, fmr. Treasury Secretary: The steep costs of health care undermine American competitiveness and are a grave threat to the nation's economic future.
Mark McClellan: In the health care reform dialogue, comparative effectiveness research offers ways to improve costs and outcomes.
Mark B. McClellan
The American Recovery and Reinvestment Act of 2009 invested $1.1 billion in federal initiatives to begin the important and necessary work of comparative effectiveness research (CER), a key building block in health care reform. However, whether CER can fulfill expectations of better quality, outcomes and value in health care will depend on how it is implemented.
A forum hosted by the Engelberg Center for Health Care Reform and The Hamilton Project addressed many of the key questions surrounding CER and featured remarks from Sen. Max Baucus (D-Mont.) and Office of Management and Budget Director Peter Orszag. Three discussion papers released at the event focus on how research questions should be prioritized, what methods and data infrastructure are needed for CER, and how CER findings can be used to improve clinical and health policy decisions. A series of distinguished panels discussed the papers' findings.Participants took questions after each panel.Watch the archived webcast » Download discussion papers »
June 9, 2009
8:30 AM - 12:45 PM EDT
The Brookings Institution
Falk Auditorium
1775 Massachusetts Ave., NW
Washington, DC
Map
Brookings Office of Communications events [at] brookings.edu (202) 797-6105
Welcome
Director, Engelberg Center for Health Care Reform and Leonard D. Schaeffer Chair in Health Policy Studies
The Future of Comparative Effectiveness Research in the United States
The Honorable Max Baucus (D-Mont.)
United States Senate
Introductory Remarks
Robert E. Rubin
Former Secretary, U.S. Department of the Treasury
Advisory Council, The Hamilton Project
Getting Our Money's Worth from Patient-Centered Health Research
Peter Orszag
Director, Office of Management and Budget
Comparative Effectiveness Research: What It Is, What It's Not and Why We Need More
Kathleen Buto
Vice President, Health Policy, Government Affairs, Johnson & Johnson
Carolyn Clancy
Director, Agency for Healthcare Research and Quality
David Lansky
President and CEO, Pacific Business Group on Health
John Rother
Executive Vice President of Policy and Strategy, AARP
Setting Priorities for Comparative Effectiveness Research (Discussion Paper 1)
Presenter: Alan Garber
Director, Center for Primary Care and Outcomes Research, Stanford School of Medicine
Presenter: David Meltzer
Associate Professor, University of Chicago School of Medicine
Mark Miller
Director, MedPAC
Elizabeth Nabel
Director, National Heart, Lung, and Blood Institute
Harold Sox
Past President, American College of Physicians
Strategies to Improve Comparative Effectiveness Research Methods and Data Infrastructure (Discussion Paper 2)
Presenter: Sean Tunis
Director, Center for Medical Technology Policy
Robert Califf
Vice Chancellor for Clinical Research and Professor of Medicine, Duke University School of Medicine
Joshua Ofman
Vice President of Global Coverage & Reimbursement and Global Health Economics, Amgen
Sebastian Schneeweiss
Assistant Professor, Harvard Medical School
Ellen Sigal
Chair and Founder, Friends of Cancer Research
From Better Evidence to Better Care: Using Comparative Effectiveness Research to Guide Practice and Policy (Discussion Paper 3)
Presenter: Steven Pearson
Director, Institute for Clinical and Economic Review
Steven Findlay
Senior Health Policy Analyst, Consumers Union
Scott Gottlieb
Resident Fellow, American Enterprise Institute for Public Policy Research
Marc Berger
Vice President, Global Health Outcomes, Eli Lilly & Co.
Sam Nussbaum
Executive VP and Chief Medical Officer, WellPoint
Closing Remarks
May 23, 2012
Blog Post
May 22, 2012, George L. Perry
Opinion
May 22, 2012, Gary Burtless
Paper
May 20, 2012, Martin Neil Baily and Bruce Katz
May 17, 2012, Ted Gayer and Phillip Swagel
May 17, 2012, Tracy Gordon
Testimony
May 16, 2012, Douglas J. Elliott
May 15, 2012, George L. Perry
Economic Studies ›
Report
October 2010, Joseph Antos, PhD, John Bertko, Michael Chernew, PhD, David Cutler, PhD, Francois de Brantes, Dana Goldman, PhD, Bob Kocher, Mark B. McClellan, Elizabeth McGlynn, PhD, Mark Pauly, PhD, Leonard Schaeffer and Stephen Shortell, PhD
May 20, 2011, Mark B. McClellan